<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01765621</url>
  </required_header>
  <id_info>
    <org_study_id>LHS022013</org_study_id>
    <nct_id>NCT01765621</nct_id>
  </id_info>
  <brief_title>Clinical and Economic Impact of an Electronic Medical Record Interfaced Decision Support System Reinforced With Patient Specific Pharmacogenetic Data for Minimizing Severe Drug-Drug Interactions</brief_title>
  <acronym>DDI+</acronym>
  <official_title>Clinical and Economic Impact of a Web Based, Electronic Medical Record Interfaced Electronic Decision Support System Incorporating Pharmacogenetic Evaluation for Physicians Intended, Mainly for Drug-drug Interaction. A Controlled Study in an Ambulatory Health Maintenance Organization Population</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Leumit Health Services</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Leumit Health Services</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Leumit Health Services, an health maintenance organization operating in Israel, will
      incorporate a web-based, decision support system for handling drug-drug interactions and drug
      information, termed DDI+ reinforced with patient specific pharmacogenetic data. The
      investigators hypothesize that implementing such a system will reduce health-care
      expenditures (e.g., hospital admissions, referrals to ERs, Imaging procedures).
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>January 2013</start_date>
  <completion_date type="Actual">October 2014</completion_date>
  <primary_completion_date type="Actual">October 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Health Services Research</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Hospital Admissions</measure>
    <time_frame>up to 12 month post initiation</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">973</enrollment>
  <condition>Healthcare</condition>
  <arm_group>
    <arm_group_label>DDI+ and Pharmacogenetic data</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>DDI+ System and Pharmacogenetic data</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Standard Care</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Control</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>DDI+ System and Pharmacogenetic Data</intervention_name>
    <arm_group_label>DDI+ and Pharmacogenetic data</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Number of chronic concomitant drugs â‰¥5

          -  treated with 1 or more drugs with a well established interaction with 1 or more of the
             following CYP450 enzymes: 2c9, 2c19, 2d6

        Exclusion Criteria:

          -  Patients diagnosed with HIV/AIDS, and/or viral hepatitis B or C
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Leumit Health Services</name>
      <address>
        <city>Tel-Aviv</city>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <verification_date>October 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 9, 2013</study_first_submitted>
  <study_first_submitted_qc>January 9, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 10, 2013</study_first_posted>
  <last_update_submitted>October 20, 2014</last_update_submitted>
  <last_update_submitted_qc>October 20, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 21, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>health care expenditure</keyword>
  <keyword>drug drug interactions</keyword>
  <keyword>electronic decision support systems</keyword>
  <keyword>pharmacogenetics</keyword>
  <keyword>Potential Reduction</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

